Standard

Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis. / Fedorova, Olga; Petukhov, Alexey; Daks, Alexandra; Shuvalov, Oleg; Leonova, Tatyana; Vasileva, Elena; Aksenov, Nikolai; Melino, Gerry; Barlev, Nikolai A.

In: Oncogene, Vol. 38, No. 12, 21.03.2019, p. 2108-2122.

Research output: Contribution to journalArticlepeer-review

Harvard

Fedorova, O, Petukhov, A, Daks, A, Shuvalov, O, Leonova, T, Vasileva, E, Aksenov, N, Melino, G & Barlev, NA 2019, 'Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis', Oncogene, vol. 38, no. 12, pp. 2108-2122. https://doi.org/10.1038/s41388-018-0566-8

APA

Fedorova, O., Petukhov, A., Daks, A., Shuvalov, O., Leonova, T., Vasileva, E., Aksenov, N., Melino, G., & Barlev, N. A. (2019). Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis. Oncogene, 38(12), 2108-2122. https://doi.org/10.1038/s41388-018-0566-8

Vancouver

Fedorova O, Petukhov A, Daks A, Shuvalov O, Leonova T, Vasileva E et al. Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis. Oncogene. 2019 Mar 21;38(12):2108-2122. https://doi.org/10.1038/s41388-018-0566-8

Author

Fedorova, Olga ; Petukhov, Alexey ; Daks, Alexandra ; Shuvalov, Oleg ; Leonova, Tatyana ; Vasileva, Elena ; Aksenov, Nikolai ; Melino, Gerry ; Barlev, Nikolai A. / Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis. In: Oncogene. 2019 ; Vol. 38, No. 12. pp. 2108-2122.

BibTeX

@article{c56758deb34d44d69a4498bda2c41719,
title = "Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis",
abstract = "Major tumor suppressor and transcription factor p53 coordinates expression of many genes hence affecting critical cellular functions including cell cycle, senescence, and apoptosis. The NR4A family of orphan receptors (NR4A1-3) belongs to the superfamily of nuclear receptors. They regulate genes involved in proliferation, cell migration, and apoptosis. In this study, we report an identification of NR4A3 as a direct transcriptional target of p53. Using various techniques, we showed that p53 directly bound the promoter of NR4A3 gene and induced its transcription. Functionally, over-expression of NR4A3 attenuated proliferation of cancer cells and promoted apoptosis by augmenting the expression of pro-apoptotic genes, PUMA and Bax. Knockdown of NR4A3 reversed these phenotypes. Importantly, NR4A3 exhibited tumor suppressive functions both in p53-dependent and independent manner. In addition, NR4A3 physically interacted with an anti-apoptotic Bcl-2 protein hence sequestering it from blunting apoptosis. These observations were corroborated by the bioinformatics analysis, which demonstrated a correlation between high levels of NR4A3 expression and better survival of breast and lung cancer patients. Collectively, our studies revealed a novel transcriptional target of p53, NR4A3, which triggers apoptosis and thus likely has a tumor suppressive role in breast and lung cancers.",
author = "Olga Fedorova and Alexey Petukhov and Alexandra Daks and Oleg Shuvalov and Tatyana Leonova and Elena Vasileva and Nikolai Aksenov and Gerry Melino and Barlev, {Nikolai A.}",
note = "Funding Information: Acknowledgements O.F., A.P. and E.V. carried out chromatin immunoprecipitation, Luciferase assay, quantitative PCR, cell-cycle analysis, colony formation assay, immunofluorescence, wound-healing and real-time cell migration assay and acknowledge the support from RCF grant 18-75-10076. A.D., O.S., N.B. carried out annexin V, co-immunoprecipitation interaction assay and the bioinformatics analysis and acknowledge the support from RFBR grant 18-29-09144. We appreciate Dr Mikhal Maliewitz (MRC Toxicology, Leicester) for a gift of NR4A1 and NR4A2 antibodies. Publisher Copyright: {\textcopyright} 2018, Springer Nature Limited. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",
year = "2019",
month = mar,
day = "21",
doi = "10.1038/s41388-018-0566-8",
language = "English",
volume = "38",
pages = "2108--2122",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "12",

}

RIS

TY - JOUR

T1 - Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis

AU - Fedorova, Olga

AU - Petukhov, Alexey

AU - Daks, Alexandra

AU - Shuvalov, Oleg

AU - Leonova, Tatyana

AU - Vasileva, Elena

AU - Aksenov, Nikolai

AU - Melino, Gerry

AU - Barlev, Nikolai A.

N1 - Funding Information: Acknowledgements O.F., A.P. and E.V. carried out chromatin immunoprecipitation, Luciferase assay, quantitative PCR, cell-cycle analysis, colony formation assay, immunofluorescence, wound-healing and real-time cell migration assay and acknowledge the support from RCF grant 18-75-10076. A.D., O.S., N.B. carried out annexin V, co-immunoprecipitation interaction assay and the bioinformatics analysis and acknowledge the support from RFBR grant 18-29-09144. We appreciate Dr Mikhal Maliewitz (MRC Toxicology, Leicester) for a gift of NR4A1 and NR4A2 antibodies. Publisher Copyright: © 2018, Springer Nature Limited. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2019/3/21

Y1 - 2019/3/21

N2 - Major tumor suppressor and transcription factor p53 coordinates expression of many genes hence affecting critical cellular functions including cell cycle, senescence, and apoptosis. The NR4A family of orphan receptors (NR4A1-3) belongs to the superfamily of nuclear receptors. They regulate genes involved in proliferation, cell migration, and apoptosis. In this study, we report an identification of NR4A3 as a direct transcriptional target of p53. Using various techniques, we showed that p53 directly bound the promoter of NR4A3 gene and induced its transcription. Functionally, over-expression of NR4A3 attenuated proliferation of cancer cells and promoted apoptosis by augmenting the expression of pro-apoptotic genes, PUMA and Bax. Knockdown of NR4A3 reversed these phenotypes. Importantly, NR4A3 exhibited tumor suppressive functions both in p53-dependent and independent manner. In addition, NR4A3 physically interacted with an anti-apoptotic Bcl-2 protein hence sequestering it from blunting apoptosis. These observations were corroborated by the bioinformatics analysis, which demonstrated a correlation between high levels of NR4A3 expression and better survival of breast and lung cancer patients. Collectively, our studies revealed a novel transcriptional target of p53, NR4A3, which triggers apoptosis and thus likely has a tumor suppressive role in breast and lung cancers.

AB - Major tumor suppressor and transcription factor p53 coordinates expression of many genes hence affecting critical cellular functions including cell cycle, senescence, and apoptosis. The NR4A family of orphan receptors (NR4A1-3) belongs to the superfamily of nuclear receptors. They regulate genes involved in proliferation, cell migration, and apoptosis. In this study, we report an identification of NR4A3 as a direct transcriptional target of p53. Using various techniques, we showed that p53 directly bound the promoter of NR4A3 gene and induced its transcription. Functionally, over-expression of NR4A3 attenuated proliferation of cancer cells and promoted apoptosis by augmenting the expression of pro-apoptotic genes, PUMA and Bax. Knockdown of NR4A3 reversed these phenotypes. Importantly, NR4A3 exhibited tumor suppressive functions both in p53-dependent and independent manner. In addition, NR4A3 physically interacted with an anti-apoptotic Bcl-2 protein hence sequestering it from blunting apoptosis. These observations were corroborated by the bioinformatics analysis, which demonstrated a correlation between high levels of NR4A3 expression and better survival of breast and lung cancer patients. Collectively, our studies revealed a novel transcriptional target of p53, NR4A3, which triggers apoptosis and thus likely has a tumor suppressive role in breast and lung cancers.

UR - http://www.scopus.com/inward/record.url?scp=85056826185&partnerID=8YFLogxK

U2 - 10.1038/s41388-018-0566-8

DO - 10.1038/s41388-018-0566-8

M3 - Article

C2 - 30455429

AN - SCOPUS:85056826185

VL - 38

SP - 2108

EP - 2122

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 12

ER -

ID: 38456367